Galectin Therapeutics Inc. (GALT)

[Darwinian]

Ahh. I see that, disappointing about the SPA.I suppose it's a delay in the larger sense but It doesn't appear to be a delay in the start of the trial, right? Says they are continuing on as a P2, just without SPA. Interesting teaser about the P1 fibrosis trial patient who had a remission of their psoriasis while taking GR-MD-02. Hope we'll hear something about the Yervoy trial soon.